Recently I am researching about DNA CLEAVAGE; ANTITUBERCULAR AGENTS; PYRIMIDINE HYBRIDS; SCAFFOLD, Saw an article supported by the UGC New Delhi, IndiaUniversity Grants Commission, India [F117.1/201617/RGNF-2015-17-SC-MAH-26074/(SAIII/Website)]; UGC-SWRO, Bangalore [F.2070-MRP/15-16/KAKA056/UGC-SWRO]. Published in ELSEVIER in AMSTERDAM ,Authors: Mane, SG; Reddy, DS; Katagi, KS; Kumar, A; Munnolli, RS; Kadam, NS; Akki, MC; Nagarajaiah, H; Joshi, SD. The CAS is 150-76-5. Through research, I have a further understanding and discovery of Mequinol. SDS of cas: 150-76-5
In this work, a series of new 8-[(substituted 2-oxo-2H-chromen-4-yOmethyl]-8-azaspiro[4.5]decane-7,9-dione derivatives (1a – 1l) is synthesized and characterized by H-1 NMR, C-13 NMR, FT-IR, GC-MS and elemental analysis. In addition, the structure of compound 1k has been elucidated using single crystal X-ray diffraction techniques. The synthesized compounds are screened for their anticancer and anti-TB activity. Preliminary anticancer results showed that compounds (1a- 1l) exhibit moderate to potent activity against MDA-MB-231, A549, HT-29 and Hela cancer cell lines. Compound if exhibited the most potent activity against MDA-MB-231cell line with IC50 value of 9.05 mu M concentration, compound lg and 1h showed potent activity against A549 cell line with IC50 value of 7.05 and 13.31 mu M concentration respectively. Compound 1j showed good cytotoxicity against Hela cell line with IC50 of 16.14 mu M, whereas, compound 1l is found to be moderately active against HT-29 cell line with IC50 of 18.07 mu M. Anti-tubercular activity revealed that compound 1c, 1d, 1g, 1h and 1j have significant activity against MTBH(37)Rv strain with MIC 0.78, 1.56, 0.19, 0.39 and 0.78 mu g/mL respectively. Further, to investigate the mechanism of anti-TB activity and detailed intermolecular interactions between the synthesized compounds, molecular docking studies are performed. (C) 2020 Elsevier B.V. All rights reserved.
About Mequinol, If you have any questions, you can contact Mane, SG; Reddy, DS; Katagi, KS; Kumar, A; Munnolli, RS; Kadam, NS; Akki, MC; Nagarajaiah, H; Joshi, SD or concate me.. SDS of cas: 150-76-5
Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
,Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles